The 13F3-treated mice showed a markedly slower tumor growth, whereas the anti-leukemic effect of 13F3 in WT B6 mice was inhibited by removing T cells with CD4 and CD8 monoclonal antibodies. The gene discussed is CD8A; the disease is neoplasm.